Microsimulation Model for Prevention and Intervention of Coloretal Cancer in China (MIMIC-CRC): Development, Calibration, Validation, and Application
Open Access
- 22 April 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 12, 883401
Abstract
Introduction: A microsimulation model provides important references for decision-making regarding colorectal cancer (CRC) prevention strategies, yet such a well-validated model is scarce in China.Methods: We comprehensively introduce the development of MIcrosimulation Model for the prevention and Intervention of Colorectal Cancer in China (MIMIC-CRC). The MIMIC-CRC was first constructed to simulate the natural history of CRC based on the adenoma-carcinoma pathway. The parameters were calibrated and validated using data from population-based cancer registry data and CRC screening programs. Furthermore, to assess the model’s external validity, we compared the model-derived results to outcome patterns of a sigmoidoscopy screening trial in the UK [UK Flexible Sigmoidoscopy Screening (UKFSS) trial]. Finally, we evaluated the application potential of the MIMIC-CRC model in CRC screening by comparing the 8 different strategies.Results: We found that most of the model-predicted colorectal lesion prevalence was within the 95% CIs of observed prevalence in a large population-based CRC screening program in China. In addition, model-predicted sex- and age-specific CRC incidence and mortality were equivalent to the registry-based data. The hazard ratios of model-estimated CRC-related incidence and mortality for sigmoidoscopy screening compared to no screening were 0.60 and 0.51, respectively, which were comparable to the reported results of the UKFSS trial. Moreover, we found that all 8 strategies could reduce CRC incidence and mortality compared to no screening.Conclusions: The well-calibrated and validated MIMIC-CRC model may represent a valid tool to assess the comparative effectiveness of CRC screening strategies and will be useful for further decision-making to CRC prevention.Keywords
Funding Information
- National Natural Science Foundation of China (82173606)
- Natural Science Foundation of Beijing Municipality (7202169)
- Beijing Nova Program (Z191100001119065)
This publication has 42 references indexed in Scilit:
- On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999–2007 – Results from the EUROCARE-5 studyEuropean Journal of Cancer, 2015
- The value of models in informing resource allocation in colorectal cancer screening: the case of the NetherlandsGut, 2015
- Cost-Effectiveness of Colorectal Cancer Screening Protocols in Urban Chinese PopulationsPLOS ONE, 2014
- Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studiesBMJ, 2014
- Modeling the Adenoma and Serrated Pathway to Colorectal CAncer (ASCCA)Risk Analysis, 2013
- Clarifying Differences in Natural History between Models of ScreeningMedical Decision Making, 2011
- Understanding Equivalence and Noninferiority TestingJournal of General Internal Medicine, 2010
- An Evidence-Based Microsimulation Model for Colorectal Cancer: Validation and ApplicationCancer Epidemiology, Biomarkers & Prevention, 2010
- Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trialThe Lancet, 2010
- Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trialThe Lancet, 2002